Bourdette, Dennis N., Daniel M. Hartung, and Ruth H. Whitham. "Practices of US health insurance companies concerning MS therapies interfere with shared decision-making and harm patients." Neurology: Clinical Practice 6.2 (2016): 177-182. Web. 10 Aug. 2022.